- The share
- Press releases
- Financial calendar
- Financial reports
- Prospectus and material offerings
- Financial presentations
- Corporate governance
- Analyst Coverage
- Code of Conduct
- Thank you
Board of Directors
Gösta Johannesson, Chairman of the Board
Chairman of the Remuneration Committee
Born 1959. B.Sc. in Business Administration and Economics. Senior adviser at Bure Equity AB. Other Board assignments: Vice Chairman of the board in Interflora AB, board member in Mentice AB (publ), Yubico AB, Scandinova Systems AB and others. Earlier Partner at Provider Venture Partners, before that executive position at Öhman Fondkommission and Handelsbanken Markets. Shareholding in XVIVO: 2 000 shares.
Chairman of the Audit Committee
Born 1964, B.Sc. in Business Administration at Stockholm school of economics. CFO at Yubico AB. Before that CFO at Cybercom and Logica. Other Board assignments: Board member in Instalco. Shareholding in XVIVO: 1 076 shares.
Member of the Audit Committee
Born 1950. MD, PhD. at University of Gothenburg. Specialist in Cardiothoracic surgery. Earlier responsible for Heart and Lung transplantation at Sahlgrenska Universitetssjukhuset. Currently General practitioner. No other Board assignments. Shareholding in XVIVO: – shares.
Member of the Board
Born 1960. 30 years’ experience from leading commercial positions at Elekta. VP Clinical Marketing Neuro Solutions. Other Board assignments: Chairman of Leksell Gamma Knife Society and boardmember of Bergvik Group AB. Shareholding in XVIVO: – shares.
Member of the Remuneration Committee and the Audit Committee
Born 1953. M. Sc. Ind. Eng. Independent Board Director and Business Advisor. Other Board assignments: Chairman of the board in Elos Medtech AB and Lyfstone A/S. More than thirty years’ experience from leading positions in fast growing companies primarily within medtech and diagnostic. Earlier CEO for CellaVision AB during 1998-2014. Shareholding in XVIVO: 3 000 shares
Member of the Board
Born 1955. DDM at Gothenburg University. Over thirty years’ experience from leading commercial positions in the medtech industry. Previously Executive VP at Dentsply and Dentsply Sirona. Other Board assignments: Board member at AddBio. Shareholding in XVIVO: 900 shares